InsiderClue
Stocks · Health care · Pharmaceutical Preparations

SUPERNUS PHARMACEUTICALS, INC.

SUPN Clue Score33
United States Fiscal year ends December CIK 0001356576 Results filed 29 Oct 2026
Add to watchlist

What the insiders did Net selling

By person

11 insiders · 23 transactions
46.6×

Jack A. Khattar holds 46.6 times base salary in stock. $48.36M of shares against $1.04M in salary for 2025.

Salary from the company's own proxy. The shares are what Jack A. Khattar last reported holding, valued at $50.48, the price Common Stock was last bought or sold at on the open market here, on 18 Mar 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Padmanabh P. Bhatt
Sr. VP of IP, CSO
—
$5.42M (7) scheduled
−$5.42M
0
0.0000%
$0.00
−100.0%
Jack A. Khattar
President, CEO
—
$1.76M (3) scheduled
−$1.76M
958,100
1.65%
$48.36M
−67.0%
Frank Mottola
SVP, Chief Tech. Ops. Officer
—
$1.10M (3) scheduled
−$1.10M
0
0.0000%
$0.00
−100.0%
Georges Gemayel
Director
—
$1.00M (2)
−$1.00M
0
0.0000%
$0.00
−100.0%
William Todd Horich
SVP, Commercial Operations
—
$483.80K (2)
−$483.80K
0
0.0000%
$0.00
−100.0%
Frederick M. Hudson
Director
—
$271.73K (1)
−$271.73K
0
0.0000%
$0.00
−100.0%
Bethany Sensenig
Director
—
$228.26K (2) scheduled
−$228.26K
0
0.0000%
$0.00
—
Jonathan Rubin
SVP, Chief Medical Officer
—
—
—
0
0.0000%
$0.00
−100.0%
Timothy C Dec
Senior Vice-President & CFO
—
—
—
0
0.0000%
$0.00
−100.0%
Charles W Newhall III
Director
—
—
—
0
0.0000%
$0.00
−100.0%
Carrolee Barlow
Director
—
—
—
0
0.0000%
$0.00
−100.0%